OP240 Incidence of hyperkalemia in patients undergoing radiopeptide therapy does not depend on the amount of co-infused amino acid infusion [Abstract]
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: European Journal of Nuclear Medicine and Molecular Imaging, 41, Supplement 2, S. S213-
- Event
-
Veröffentlichung
- (where)
-
Augsburg
- (who)
-
Universität Augsburg
- (when)
-
2014
- Event
-
Veröffentlichung
- (where)
-
Berlin
- (who)
-
Springer
- (when)
-
2014
- Creator
- DOI
-
10.1007/s00259-014-2901-9
- URN
-
urn:nbn:de:bvb:384-opus4-637536
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wolf, Herta
- Lapa, Constantin Frederik Victor
- Bluemel, Christina
- Buck, Andreas K.
- Herrmann, Ken
- Universität Augsburg
- Springer
Time of origin
- 2014
Other Objects (12)
Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy
Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy
Molekulare Bildgebung der Proliferation in vivo mit Positronen-Emissions-Tomographie
Primary bone marrow diffuse large B-cell lymphoma affecting distal parts of the legs as a cause of persisting B symptoms
Lenvatinib : Multikinaseinhibitoren - die erste effektive Therapie für das Radiobiod-refraktäre differenzierte Schilddrüsenkarzinom
Combination therapies to enhance the efficacy of PSMA-targeted radioligand therapy in prostate cancer
Pretherapeutic estimation of kidney function in patients treated with peptide receptor radionuclide therapy: can renal scintigraphy be safely omitted?
Paralytic subileus as an adverse effect of amino acid–based nephroprotection in a patient undergoing peptide receptor radionuclide therapy
OP247 Role of PSMA-PET/CT in biochemical relapse during follow-up of prostate cancer patients [Abstract]
18FDG-PET/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantation
18FDG-PET/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantation
"Somatostatin receptor expression in Merkel cell carcinoma as target for molecular imaging"
Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy
Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy
Molekulare Bildgebung der Proliferation in vivo mit Positronen-Emissions-Tomographie
Primary bone marrow diffuse large B-cell lymphoma affecting distal parts of the legs as a cause of persisting B symptoms
Lenvatinib : Multikinaseinhibitoren - die erste effektive Therapie für das Radiobiod-refraktäre differenzierte Schilddrüsenkarzinom
Combination therapies to enhance the efficacy of PSMA-targeted radioligand therapy in prostate cancer
Pretherapeutic estimation of kidney function in patients treated with peptide receptor radionuclide therapy: can renal scintigraphy be safely omitted?
Paralytic subileus as an adverse effect of amino acid–based nephroprotection in a patient undergoing peptide receptor radionuclide therapy
OP247 Role of PSMA-PET/CT in biochemical relapse during follow-up of prostate cancer patients [Abstract]
18FDG-PET/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantation
18FDG-PET/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantation
"Somatostatin receptor expression in Merkel cell carcinoma as target for molecular imaging"
Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy
Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy
Molekulare Bildgebung der Proliferation in vivo mit Positronen-Emissions-Tomographie
Primary bone marrow diffuse large B-cell lymphoma affecting distal parts of the legs as a cause of persisting B symptoms
Lenvatinib : Multikinaseinhibitoren - die erste effektive Therapie für das Radiobiod-refraktäre differenzierte Schilddrüsenkarzinom
Combination therapies to enhance the efficacy of PSMA-targeted radioligand therapy in prostate cancer
Pretherapeutic estimation of kidney function in patients treated with peptide receptor radionuclide therapy: can renal scintigraphy be safely omitted?
Paralytic subileus as an adverse effect of amino acid–based nephroprotection in a patient undergoing peptide receptor radionuclide therapy
OP247 Role of PSMA-PET/CT in biochemical relapse during follow-up of prostate cancer patients [Abstract]
18FDG-PET/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantation
18FDG-PET/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantation